ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36535
0.00%
Bitcoin
67,640.46
0.24%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GRI Bio Inc (GRI)

  7. GRI Bio Inc (GRI) News

GRI

GRI Bio (GRI)

GRI Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GRI
DateTimeSourceHeadlineSymbolCompany
05/22/20248:15AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) ProgramsNASDAQ:GRIGRI Bio Inc
05/21/20247:35AMGlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)NASDAQ:GRIGRI Bio Inc
05/20/20247:45AMGlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:GRIGRI Bio Inc
05/14/20248:05AMGlobeNewswire Inc.GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company ShowcaseNASDAQ:GRIGRI Bio Inc
05/13/20247:00AMGlobeNewswire Inc.GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
04/29/20247:45AMGlobeNewswire Inc.GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on AutoimmunityNASDAQ:GRIGRI Bio Inc
04/25/20248:15AMGlobeNewswire Inc.GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarNASDAQ:GRIGRI Bio Inc
04/16/20247:35AMGlobeNewswire Inc.GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentNASDAQ:GRIGRI Bio Inc
04/08/20247:35AMGlobeNewswire Inc.GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceNASDAQ:GRIGRI Bio Inc
04/01/20246:35AMGlobeNewswire Inc.GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
03/28/20248:00AMGlobeNewswire Inc.GRI Bio to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:GRIGRI Bio Inc
03/14/20247:45AMGlobeNewswire Inc.GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsNASDAQ:GRIGRI Bio Inc
03/04/20247:30AMGlobeNewswire Inc.GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomNASDAQ:GRIGRI Bio Inc
02/02/20247:00AMGlobeNewswire Inc.GRI Bio Announces Pricing of $5.5 Million Public OfferingNASDAQ:GRIGRI Bio Inc
01/26/20247:05AMGlobeNewswire Inc.GRI Bio Announces Reverse Stock SplitNASDAQ:GRIGRI Bio Inc
12/05/20238:05AMGlobeNewswire Inc.GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)NASDAQ:GRIGRI Bio Inc
11/27/20237:35AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)NASDAQ:GRIGRI Bio Inc
11/15/20237:05AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
10/31/20237:45AMGlobeNewswire Inc.GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune DiseasesNASDAQ:GRIGRI Bio Inc
10/19/20237:45AMGlobeNewswire Inc.GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung ConferenceNASDAQ:GRIGRI Bio Inc
10/17/20237:35AMGlobeNewswire Inc.GRI Bio Announces Partnership with the Respiratory Translational Research Collaboration to Advance Leading NKT Regulation Technology Targeting Earlier in the Inflammatory Cascade to Modulate Disease ProgressionNASDAQ:GRIGRI Bio Inc
10/11/20238:05AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO ConferenceNASDAQ:GRIGRI Bio Inc
10/05/20237:45AMGlobeNewswire Inc.GRI Bio Announces Publication of Comprehensive Invariant NKT (iNKT) Cell Review in Frontiers in Immunology Demonstrating a Key Role of Type 1 iNKT Cells in Modulating Various Fibrotic ConditionsNASDAQ:GRIGRI Bio Inc
09/06/20238:05AMGlobeNewswire Inc.GRI Bio to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:GRIGRI Bio Inc
08/23/20238:00AMGlobeNewswire Inc.GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIRNASDAQ:GRIGRI Bio Inc
08/14/20237:05AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
08/07/20237:35AMGlobeNewswire Inc.GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal ModelsNASDAQ:GRIGRI Bio Inc
08/03/20237:30AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech ConferenceNASDAQ:GRIGRI Bio Inc
07/24/20238:00AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight EventNASDAQ:GRIGRI Bio Inc
07/05/20237:45AMGlobeNewswire Inc.GRI Bio, Inc. (NASDAQ: GRI) to Participate in the Virtual Investor Summer Spotlight SeriesNASDAQ:GRIGRI Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRI

Your Recent History

USOTC
HMBL
HUMBL (PK)
AMEX
FOXO
FOXO Technologies
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
DRNK
NoHo (PK)
USOTC
CATV
4Cable TV (PK)
USOTC
IFUS
Impact Fusion (PK)
NASDAQ
COOP
Mr Cooper
USOTC
GNCP
GNCC Capital (CE)
NASDAQ
NB
NioCorp Developments
NASDAQ
PLUG
Plug Power
USOTC
CEOS
CeCors (PK)
USOTC
KEGS
1812 Brewing (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
RVNC
Revance Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved